Hepatitis C SIG Poster Highlights

Nov 09 2025
Convention Center: Science in the Park - Site A - Level 3
9:45 AM - 10:15 AM

World Class Speakers

SS
Presenter

Stacey Scherbakovsky, PharmD
MB
Presenter

Marc Bourliere, MD

Hopital Saint Joseph
Limas Kupcinskas, MD, PhD
Presenter

Limas Kupcinskas, MD, PhD

Lithuania University of Health Sciences
Harrys A Torres, MD, FAASLD
Moderator

Harrys A Torres, MD, FAASLD

The University of Texas MD Anderson Cancer Center
Ponni V. Perumalswami, MD, FAASLD
Moderator

Ponni V. Perumalswami, MD, FAASLD

University of Michigan Medical Center

Description

Join us for a poster highlight of the top abstracts from the Hepatitis C SIG. 
 

Journey Maps

Presentations

9:45 AM - 9:48 AM
Jun 25 2026
Convention Center - Science in the Park - Site A - Level 3

Welcome & Introductions

Harrys A Torres, MD, FAASLD , Moderator
Hepatitis
9:48 AM - 9:53 AM
Jun 25 2026
Convention Center - Science in the Park - Site A - Level 3

Cumulative Review of Sofosbuvir/Velpatasvir Exposure in Pregnant Women with Hepatitis C Virus from a Pharmacovigilance Safety Database.

Stacey Scherbakovsky, PharmD , Presenter
Hepatitis
9:53 AM - 9:58 AM
Jun 25 2026
Convention Center - Science in the Park - Site A - Level 3

Is SVR4 Testing an Acceptable Alternative Measure of HCV Cure in Re-Treated Patients Following DAA Failure? A SVR4/12 Concordance Evaluation from the POLARIS Clinical Trials

Marc Bourliere, MD , Presenter
Hepatitis
9:58 AM - 10:03 AM
Jun 25 2026
Convention Center - Science in the Park - Site A - Level 3

National population-based hepatitis C screening and elimination programme in Lithuania: what results have we achieved?

Limas Kupcinskas, MD, PhD , Presenter
Hepatitis
10:03 AM - 10:15 AM
Jun 25 2026
Convention Center - Science in the Park - Site A - Level 3

Q&A/Panel Discussion/Closing

Ponni V. Perumalswami, MD, FAASLD , Moderator
Hepatitis